|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
5/11/18 Vickers Philip J. 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Russell Angus C. 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Gardner Phyllis 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Gangolli Julian S 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Foley Mark J 4 Director² 1:7K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Byrnes Robert F 4 Director² 1:6K Revance Therapeutics, Inc. Revance Theraps, Inc.
5/11/18 Revance Therapeutics, Inc. 8-K:1,5,9 5/10/18 2:261K
____________ | ¹ | Filing/Form Types: | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|